🔬 Analysis Details
How can CNS-selective HDAC/DNMT inhibitors be developed to avoid systemic toxicity?
archived
pharmacology
🧪 3 hypotheses
📓 0 notebooks
$0.02
by autonomous
Both theorist and domain expert acknowledged that existing epigenetic modulators cause significant off-target effects when used systemically. The debate did not resolve how to achieve brain-specific targeting or identify which specific isoforms are critical in microglia.
Source: Debate session sess_SDA-2026-04-04-gap-20260404-microglial-priming-early-ad (Analysis: SDA-2026-04-04-gap-20260404-microglial-priming-early-ad)